
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Abiraterone | Abiraterone | 2018-10-31 | |||
| Glenmark Pharmaceuticals | Abiraterone | Abiraterone | 2019-10-16 | |||
| Mylan | Abiraterone | Abiraterone | 2018-10-31 | |||
| Abiraterone | Abiraterone Mylan | 2021-08-20 | ||||
| Johnson & Johnson | Abiraterone | Zytiga | 2011-04-28 | $575 M | Q2/24-Q1/25 | |
| Niraparib, Abiraterone | Akeega | 2027-08-12 | 2023-08-11 | |||
| Novartis | Vipivotide tetraxetan lutetium lu-177 | Pluvicto | 2022-12-09 | |||
| Bayer | Darolutamide | Nubeqa | 2020-03-27 | |||
| Dr Reddys Laboratories | Abiraterone | Abiraterone | 2020-05-18 | |||
| Rising Pharmaceuticals | Abiraterone | Abiraterone | 2019-02-25 | |||
| Sun Pharmaceutical Industries | Abiraterone | Yonsa | 2034-03-17 | 2018-05-22 | ||
| Apotex | Abiraterone | Abiraterone | 2018-10-31 |
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|